^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Non Small Cell Lung Cancer |
| Drug: | Gilotrif (afatinib) (EGFR inhibitor, HER2 inhibitor, HER4 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
09/25/2013
Excerpt:
Giotrif as monotherapy is indicated for the treatment of…locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy.
